Blood Stream Infection Testing Market To Surpass US$ 7,728.4 Million By 2026

 

Global Blood Stream Infection Testing Market, by Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 3,758.7 million in 2017, and is projected to exhibit a CAGR of 8.4% over the forecast period (2019 – 2026), as highlighted in a new report published by.

Increasing prevalence of abdominal infection, dental infection, kidney and urinary infection, and chronic diseases is expected to augment the market growth Increasing prevalence of abdominal infection and dental infection and growing geriatric population are factors fueling the market growth. The Global Burden of Disease Study 2016 estimated that oral disease affects half of the world’s population i.e. 3.58 million people with dental carries. Globally it is estimated that 2.4 billion people suffer from carries of permanent teeth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global blood stream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly infected in 2017 globally.  Furthermore, advancements in diagnostic testing is expected to fuel the market growth over the forecast period.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1727

For instance, in 2017, researchers from the University of Illinois and Charle Foundation Hospital completed a clinical study of a device that can detect sepsis from a single drop of blood. In April 2017, BioMérieux, a major player in the field of in vitro diagnostics, announced that BacT/ALERT VIRTUO, its fully automated blood culture system, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This innovative blood culture microbial detection system enhances the blood culture performance for rapid detection, thereby offering faster identification of bloodstream infection.

Browse 22 Market Data Tables and 20 Figures spread through 178 Pages and in-depth TOC on “Blood Stream Infection Testing Market”- Global Forecast to 2026, by Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-Conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Key players in the market are focused on launching new tests for detection of various infectious diseases. For instance, in October 2018, Becton, Dickson and Company launched the molecular test to detect the tuberculosis and multidrug resistant tuberculosis.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/blood-stream-infection-testing-market-1727

Key Takeaways of the Blood Stream Infection Testing Market:

The global blood stream infection testing market is expected to exhibit a CAGR of 8.4% over the forecast period, owing to high prevalence of abdominal infections, dental infections, and chronic diseases

Among product type, the instruments segment held dominant position in the blood stream infection testing market in 2018, owing to various new innovations by the key players for synthesizing bloodstream infection tests to detect the infectious diseases.

Major companies operating in the global blood stream infection testing market include, bioMérieux SA, Becton,Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1727

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Microplate Readers Market Size, Trends, Shares, Insights and Forecast – 2018-2026

 

Microplate Readers Market, by Well Type (96 Wells, 384 Wells, 1536 Wells, and Others), by Reader Type (Single-mode Readers and Multi-mode Readers), by End User (Biotechnology and Pharmaceutical Companies, Research Institutes, Contract Research Organizations and Others), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Microplate readers, also called as microplate photometers are laboratory instruments used for the detection of chemical or physical events of samples in microtiter plates. These plates are used for various research experiments in bioassay validation, drug discovery, manufacturing processes in biotechnological and pharmaceutical industries, quality control, and academic organizations. The microplate readers are able to detect physical, chemical or biological reactions by measuring emitted light. These readers help to minimize operational time, save cost, and facilitates researchers with easy data analysis through generation of actionable results. Common detection modes for microplate assays include fluorescence, absorbance, luminescence, fluorescence polarization, time resolved fluorescence, and others. The sample reactions can be assayed from 6 wells to 1536 well type microtiter plates. Multimode plate readers can perform a wide range of applications that include protein and cell growth assays, ELISA, reporter assays, molecular interactions, enzyme activity, ATP quantification, immunoassays, and others. Higher density micro plates are used mostly for advanced screening applications with a typical assay volume residing between 5-50 µl per well.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1753

Market Dynamics

Increasing incidence of infectious diseases is propelling demand for development of fast and efficient therapeutics, vaccines, and other medications, which is propelling demand for microplate readers. Infectious diseases such as influenza and other vector borne diseases that requires high throughput screening for drug development are expected to drive growth of the global microplate readers market size. According to World Health Organization (WHO), 2017, the incidence of dengue increased significantly, indicating around 390 million dengue infections per year all around the world. According to the International Journal of Nanomedicine, 2015, an estimated 212 malaria cases were registered globally with 429,000 deaths. Moreover, increasing investments in research and development to upgrade the laboratories with advanced technologies that will help in accelerating the drug development procedure is also expected to fuel the growth of global microplate readers market. For instance, in September 2016, Biocon’s contract research arm, Syngene International established a multi-disciplinary development center and drug discovery research laboratory for Amgen in Bengaluru, named Amgen Research and Development Center (SARC). High penetration of alternate methods to carry out detection of biological procedures is expected to hinder the market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/microplate-readers-market-1753

Regional Insights

On the basis of region, the global microplate readers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global microplate readers market and is expected to retain its dominance over the forecast period. This dominance attributes to the rising incidence of epidemic diseases as well as early diagnosis and treatment of diseases. For instance, according to the Centers of Disease Control and Prevention (CDC), 2017, the vector borne disease cases in the U.S. has tripled from 2004 to 2016. Moreover, the paradigm shift of scientific bio-labs towards automated tools for conducting various assays is fueling growth of the global microplate readers market in North America region. For instance, in 2012, Hudson Robotics, Inc. introduced SOLO Automated ELISA Workstation, with liquid handlers and microplate readers as a simple, low-cost yet efficient ELISA preparation workstation that supports serial dilutions to study concentration-dependent effects.

Furthermore, Asia Pacific is expected to witness a significant growth in the market, owing to developments in healthcare infrastructure, increasing investment in research and development by various regional pharmaceutical and biotechnology companies. For instance, in October 2016, Sun Pharma, an India-based pharmaceutical company announced plans to increase its research development by investing in a new R&D unit at Madhya Pradesh, India.

Competitive Landscape

Key players operating in the global microplate readers market include Thermo Fisher Scientific, Inc., PerkinElmer, Inc., MDS Analytical Technologies, Corning, Grenier Bio-One, Tecan, BioTek Instruments, Inc., BMG LABTECH GmbH Instruments, Inc., and others. Market players are focused towards providing technologically advanced products to sustain their presence in the market. For instance, in August 2017, BioTek Instruments, Inc. introduced next generation 800 TS microplate reader and 50s washer that has a color touchscreen interface with easily programmed onboard software to expand application base of microplate readers to kinetic assays such as biomagnetic separation and others.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1753

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Gastrointestinal Stents Market Size Share Trends Forecast Analysis 2026

 

Gastrointestinal Stents Market – Market Dynamics

Growth of the global Gastrointestinal Stents Market is expected to be fuelled by increasing product launches with novel technology by key players in the market. For instance, in 2013, Cook Medical Inc. received U.S. Food and Drug Administration (FDA) for biliary stent, adding to the line of controlled-release gastrointestinal tract. Moreover, Evolution biliary stent incorporates patency design, to prevent migration of stent after its insertion. Furthermore, in 2012, Boston Scientific Corporation launched WallFlex, biliary Transhepatic Stent System for the treatment of benign biliary strictures. Companies are focusing on manufacturing stents with biodegradable material to eliminate stent removal procedures. However, implantable products are subjected to stringent regulations, and this is expected to hinder growth of the gastrointestinal stent market. Moreover, complication associated with gastrointestinal stent implantation is also expected to be major factor leading to low adoption of these device.

Stents are tubular device used for insertion in lumen such as esophagus, colon or blood vessel. Stents are safe and effective alternative to surgery or repetitive endoscopic procedures. Gastrointestinal stents are used to open bile ducts, esophagus, small bowel, and colon when blocked by large, cancerous tissue growth. Stents can be removable or permanently implantable based on the material used. The role of stenting is decreasing patients’ digestive tract obstruction. Moreover, advancement in technology has led to improvement in stent performance and reduced stent-induced complications to improve quality of life and this is expected to propel the gastrointestinal stent market growth.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1756

Increasing demand for minimally invasive procedures is expected to be a major factor driving growth of gastrointestinal stents market size. Gastrointestinal stenting is considered as minimally invasive therapy and is increasingly gaining popularity, owing to its advantages such as low risk of infection, less recovery time as compared to conventional open surgery procedures, and reduced hospital stay.

Increasing prevalence of urological and gastrointestinal disorders are propelling demand of gastrointestinal stents during the forecast period. According to Center for Disease Control and Prevention (CDC), in 2015, number of adults diagnosed in U.S. with ulcer in digestive tract are 14.7 million, comprising 6% of the total adult population. Moreover, according to American Cancer Society’s estimation for year 2018 suggests that 9,220 new cases of colon cancer are expected to be diagnosed in the U.S. Moreover, increasing number of patients with gastrointestinal tumors is also adding to patient pool that can be subjected to gastrointestinal stent implantation.

Gastrointestinal Stents Market - Regional Analysis

Regional segmentation of Gastrointestinal Stents Market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held the dominant position in the gastrointestinal stents market in 2017 and is expected to retain its dominance over the forecast period. This is owing to increasing number of intestinal cancer cases and favorable reimbursement policies in the region. For instance, in 2017, American Cancer Society estimated 4,000 to 6,000 cases each year in the U.S. for gastrointestinal stromal tumors.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/gastrointestinal-stents-market-1756

Gastrointestinal Stents Market – Competitive Analysis

Major market players operating in the gastrointestinal stents market are Boston Scientific Corporation, Medtronic plc, Olympus Medical System, Cook Medical, Ella-CS, Endo-Flex, Diagmed Healthcare, Micro-Tech, W. L. Gore & Associates and Taewoong Medical Co., Ltd.

Market players are focusing on inorganic strategies such as mergers, acquisitions, or collaborations to increase their foothold in the market. For instance, in May 2018, Olympus— a company that designs and delivers innovative solutions for medical and surgical procedures—entered into an agreement with M.I. Tech, a company that designs stents and other devices. Under this agreement, HANAROSTENT, biliary and esophagus stents rolled in the EndoTherapy product portfolio of the company. The displacement of the stents is a major issue faced after the stent is been placed. Targeting these issues, in 2017, W. L. Gore & Associates, the manufacturer of Gore Viabil short wire biliary endoprosthesis stent, launched anti-migration assurance program, under which device will be replaced within a period of one year if it migrates. Furthermore, in 2016, Boston Scientific launched AXIOS stent and Electrocautery Enhanced delivery system, endoscopic system used for minimally invasive treatment of pancreatitis, obtained as a part of acquisition of Xlumena. In 2015, Cardinal Health announced acquisition of Cordis, business of Johnson & Johnson, for US$ 1.944 Bn.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1756

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Cellulite Treatment Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027

 

Cellulite Treatment Market – Regional Insights

On the basis of the region, the global Cellulite Treatment Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global market, owing to adoption of the innovative medical products and treatments, For instance, in 2015, The Food and Drug Administration (FDA) approved Cellina, a non-invaise cellulite treatment. Moreover U.S is observing fast increase in aging population, is expected to create robust demand for aesthetic repair market services in the country. For instance, According to the American Society for Aesthetic Plastic Surgery (ASAPS) 2016 report, it was estimated that over 11 million aesthetic procedures were performed by board?certified specialists, of which 16.5% were surgical procedures and 83.5% were non?surgical procedures.

Cellulite Treatment Market – Dynamics

One of the major drivers propelling growth of the cellulite treatment market is the growing obese population. For instance, according to 2014 National Institute of Diabetes and Digestives and Kidney Diseases report, 2 in 3 adults (70.2 percent) were diagnosed with obesity in the U.S. Moreover, advancements in technology such as Cellulaze™ the world's first and only minimally invasive medical device designed to eliminate cellulite which uses SideLight 3D side-firing technology to target the causes of cellulite beneath the skin, are boosting the growth of the cellulite treatment market size. For instance, according to 2017, American Society of Plastic Surgeons report, around 1.8 million cosmetic surgical procedures were performed in 2017. Growing inclination towards achieving a slim body, lighter complexion, and better skin is also boosting demand for cosmetic treatment for cellulite. Furthermore, various technological advancement such as user-friendly pen shaped portable laser medical devices, is expected to boost growth of the market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1773

However, a major factor restraining growth of the cellulite treatment market is a popular alternative herbal massage treatment, which includes acupuncture, gua sha, and cupping techniques. Furthermore, high cost of cosmetic surgeries are expected to hamper the market growth.

Cellulite is a condition in which a person’s skin of their thighs, buttocks, and hips appears dimpled. Common names for cellulite include cottage cheese skin, orange-peel skin, hail damage, and the mattress phenomenon. This condition is commonly observed in women than in men due to the fat deposition in a normal women represents between 18% and 20% of body weight, whereas in men it represents only 10% to 15%. According to 2015, article published by American Journal of Clinical Dermatology, around 80 and 90 percent of women are affected by cellulite at some point in their lives. Appearance of lumpiness beneath the skin due to fat deposits distorts and pushes the connective tissues, thus leads to the characteristic of cotton cheese appearance of the skin. Causes of cellulite are unidentified, however it seems to result from an interface between the fat layer and connective tissue in the dermatological layer, which is below the surface of the skin. Hormones such as noradrenaline, insulin, estrogen, prolactin, thyroid hormones play a significant role in cellulite development. Moreover, other factors such as genetics, age, diet, and lifestyle also affect cellulite development. Cellulite treatment market is significantly gaining traction due to increasing prevalence of obesity.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/cellulite-treatment-market-1773

Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to growing obese population in this region and increasing disposable income among the populace in the region.  According to 2017 Asian Development Bank Institute report Asia and the Pacific region is home to the largest absolute number of overweight and obese people, equivalent to about 1 billion.

Cellulite Treatment Market – Competitive Insights

Key players operating in the global cellulite treatment market include Tanceuticals, LLC., Nubway, Merz Pharma GmbH & Co. KGaA, Zimmer Aesthetics, Cymedics, Cynosure, Inc., Inceler Medikal Co. Ltd., and Syneron Medical Inc. Market players are focused towards collaborations and providing technologically advanced products to sustain their presence in the market.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1773

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Non-Surgical Skin Tightening Market Trends Forecast Opportunity Analysis-2027

 

Non-Surgical Skin Tightening Market – Regional Insights

On the basis of region, the global Non-Surgical Skin Tightening Market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America holds the dominant position in market, owing to increasing awareness of people in the region about one’s aesthetic appeal. Moreover, presence of major market players like Sciton, Inc. and Cynosure Inc. in this region especially in the U.S., is also a major factor accelerating growth of non-surgical skin tightening market size in this region. Furthermore, increasing number of players are launching advanced products in the region for skin tightening. For instance, in 2018, NuFace launched first-ever, FDA-cleared, microcurrent skin toning device, NuBODY, for smoothing of dimpled and uneven skin on the body.

The recent past has witnessed increasing use of non-invasive skin tightening procedures instead of conventional plastic surgeries. This is owing to increasing awareness regarding non-invasive procedures. Increasing number of people are focusing on one’s aesthetic appeal and this has led to increasing demand for such non-surgical procedures for skin tightening. These procedures aid in reducing wrinkles and improve the texture of the skin, which is used by individuals. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS) 2016 report, it was estimated that over 11 million aesthetic procedures were performed by board?certified specialists, of which 16.5% were surgical procedures and 83.5% were non?surgical procedures. Several types of products are available in the market such as ultrasound devices, laser-based devices, and RF devices for conducting various non-surgical skin tightening procedures

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1776

Non-Surgical Skin Tightening Market – Dynamics

Skin tightening procedures are increasing gaining popularity, especially non-invasive procedures that aid in improving skin laxity. In order to improve one’s aesthetics, people for opting for these procedures. This is a major factor for growth of the market. Moreover, dermatologists are also recommending non-surgical treatment for skin tightening than of invasive procedures. Furthermore, lower cost of these procedures in comparison to invasion surgeries, is another factor for high adoption of these procedures and this is expected to support growth of the market. For instance, according to 2016 American Society of Plastic Surgeons (ASPS) report a normal invasive cosmetic surgery procedure costs about US$ 3,000 to US$ 5,000 each, whereas minimally invasive cosmetic procedures cost around US$ 300 to US$ 650 each. Another factor aiding in growth of the market is increasing approvals for advanced products such as laser products for skin tightening. For instance, in 2015, aesthetic laser systems manufacturer, DEKA Medical, received FDA clearance for its Synchro laser systems.

However, stringent regulations for aesthetic procedures, and high health risk sue to exposure to radiations are expected to hamper growth of the market. For instance, according to a published report in 2011 International Agency for Research on Cancer (IARC) showed the cancer risks involved with use of RF devices. Moreover, repeated treatment is required to maintain the skin and its texture. Therefore, patients have to invest high capital for these repetitive treatments. This could also reduce adoption of such non-surgical procedures thereby, restraining the market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/non-surgical-skin-tightening-market-1776

Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing rising number of improvements in healthcare infrastructure and rising acceptance of aesthetic procedures within population. Moreover lower cost of cosmetic procedures within the region are gaining attraction of customers from various parts of the world as well. For instance, according to Korea Health Industry Development Institute 2015 survey, 41,263 international patients went through cosmetic and plastic surgery procedures in South Korea.

Non-Surgical Skin Tightening Market – Competitive Landscape

Key players operating in the global non-surgical skin tightening market include Fotona d.d.,  Solta Medical Inc., Alma Lasers Ltd., Cynosure Inc., Lynton Lasers Ltd., Strata Skin Sciences Inc., Cutera Inc., Sciton, Inc., Lutronic Corporation, Venus Concept Canada Corp., and EL.En. S.p.A., Lumenis Ltd. Major players are engaged in developing advanced technologies for skin tightening and are focusing on collaborations, in order to retain dominant position in the market. For instance, in 2017, Silk'n launched, FDA cleared skin tightening device, Titan that works with harmonized energy technology to reduce wrinkles and lift facial contours.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1776

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Cervical Total Disc Replacement Devices Market, To Surpass US$ 5,312.8 Million By 2027

 

Global Cervical Total Disc Replacement Devices Market, By Material (Metal-on-metal and Metal-on-biocompatible), By Design (Constrained, Semi-constrained, and Unconstrained), By End User (Hospitals, Ambulatory Surgical Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,105.1 million in 2019 and is expected to exhibit a CAGR of 21.7% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

Market players are more focused on adoption of inorganic growth strategies such as acquisitions, collaborations, and partnerships to strengthen their position in the cervical total disc replacement device market. For instance, in March 2018, Orthofix International N.V., a global medical device company, announced the acquisition of Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs. With this acquisition, Orthofix added Spinal Kinetics’ M6 artificial discs including M6-C cervical and M6-L lumbar artificial discs for patients suffering from degenerative disc disease (DDD) of the spine to its portfolio.

Moreover, various companies are developing advance solutions for treatment of cervical disc disease. Surgical methods such as artificial disc replacement surgeries and spinal fusion surgeries are costly which has created opportunities for manufacturers to provide low cost surgeries in middle income countries and support growth of the degenerative disc disease treatment market. For instance, according to the Spine and Neuro Surgery Hospital India, cost of disc replacement surgery in India ranges from US$ 3,500 to US$ 5,500, which is considerably less than the cost of surgery in the U.S. or U.K.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1763

Browse 35 Market Data Tables and 31 Figures spread through 160 Pages and in-depth TOC on Global Cervical Total Disc Replacement Devices Market, By Material (Metal-on-metal and Metal-on-biocompatible), By Design (Constrained, Semi-constrained, and Unconstrained), By End User (Hospitals, Ambulatory Surgical Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), – Global Forecast to 2027

Development of innovative treatments for degenerative disc disease (DDD) and product approvals are contributing to the growth of the market. For instance, in July 2016, Medtronic plc. received the U.S. Food and Drug Administration (FDA) approval for its two-level Prestige LP Cervical Disc Procedure for treatment of cervical disc disease causing nerve or spinal cord compression at two adjacent levels between the C3-C7 segments of the neck.

Moreover, the increasing healthcare expenditure is expected to boost growth of the global cervical total disc replacement device market during the forecast period. For instance, according to the National Health Expenditure report, people in the U.S. spent over US$ 1 trillion on healthcare in 2018.

Adoption of inorganic growth strategies by key player is another factor driving the cervical total disc replacement devices market growth. For instance, in June 2018, Zimmer Biomet Holdings, a manufacturer of musculoskeletal devices, acquired LDR Holding Corp (LDRH) for US$ 1 billion. With this acquisition, the company added LDR’s Mobi-C cervical disc replacement and Mivo lumbar and cervical fusion devices to its Spine & Craniomaxillofacial (CMF) business.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/cervical-total-disc-replacement-device-market-1763

Key Takeaways of the Global Cervical total disc replacement devices market:

The global cervical total disc replacement devices market is expected to exhibit a CAGR of 21.7% over the forecast period (2019-2027) owing to launches of cervical total disc replacement devices in the market. In October 2018, Zimmer Biomet Holdings, Inc. launched its novel Mobi-C Cervical Disc for cervical total disc replacement in Japan. The product was approved by the Japan Ministry of Health, Labour and Welfare (MHLW) in May 2018.

Among material, the metal-on-biocompatible segment is expected to drive the market growth owing to product launches. For instance, in September 2019, NuVasive, Inc. launched Modulus Cervical, a porous titanium interbody implant for cervical applications.

Some of the major players operating in the global cervical total disc replacement devices market include Stryker Corporation, Medtronic Plc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics, Orthofix Medical Inc., NuVasive Inc., and Centinel Spine, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1763

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Urodynamic Equipment Market Size, Trends, Shares, Insights and Forecast – 2018-2026

 

Urodynamic Equipment Market Regional Analysis:-

North America region is expected to hold dominant position in global Urodynamic Equipment Market, owing to initiatives taken by the medical centers to increase the awareness among the people. For instance, in 2017, Urology Foundation Care and American Urological Association took an initiative called Bladder Health Month which took place in November. As a part of the campaign, a group of patients, doctors, clinicians share some facts related to urinary incontinence to spread awareness among people regarding treatment of urinary disorders. Such initiatives create awareness among people regarding disease and their treatment options. In 2018, an initiative taken by bladder cancer advocacy network called as ‘Shine a Light’ campaign aimed to create awareness about bladder cancer and its treatment methods. Various other campaigns taken by bladder cancer advocacy network include walks to end bladder cancer and my bladder cancer story campaign. Also, bladder cancer advocacy network uses media to spread awareness through articles, social networking sites, etc. Such initiatives area expected to drive growth of urodynamic equipment market share in North America.

The Urinary tract of the human body functions to remove extra water and wastes. Urodynamic or Urodynamic test studies the working of urethra, sphincters, and bladder. Urodynamic examines functions of bladder and urethra of storing and releasing urine from the body. Tests detects involuntary contractions of bladder that results into leakage of urine. Urodynamic tests are majorly conducted for women with incontinence and men having enlarged prostate glands. Test ranges from simple observation to precise and accurate measurements. Simple observations include volume of urine produced, inability or ability to stop the flow of urine in midstream, and length of time taken to produce urine. Precise measurements include imaging equipment, which takes pictures of the urinary bladder emptying and filling urine, pressure monitors are used record pressure inside the bladder, and sensors record nerve and muscle activity. Urodynamic tests consist of uroflowmetry, cystometric test, postvoid residual measurement, leak point pressure measurement, pressure flow study, electromyography, and video urodynamic test.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1777

Urodynamic Equipment Market Drivers:-

Initiatives taken to increase awareness among people such as by World Continence Week organized by Continence Foundation of Australia is expected to support the global urodynamic equipment market growth. The World Continence Week 2017, aims to spread awareness regarding in continence. According to a study conducted by International Continence Society in 2018, the prevalence of urinary incontinence in women is 28%, 16.1% in men, and 35% in senior citizens. This study also states that urinary incontinence is among the 10 most common diseases caused in both sexes. Moreover, aging is also one of the reasons that can cause urinary bladder related disorders. According to National Institute of Health in 2016, incidence of bladder cancer is 7 times more in senior citizens whose age is 65 and above. According to International Continence Society, individuals suffering from asthma or bronchitis are 38% more likely to have urinary incontinence. According to a study conducted by Asthma and Allergy Foundation of America and Centers for Disease and Prevention (CDC) in 2016, 1 out of 13 people are suffering from asthma i.e. about 25 million people are suffering from asthma in the U.S. In 2015, around 47.5% of children under the age of 18 had asthma. Therefore, increase in chronic and urinary diseases is driving growth of the urodynamic equipment market.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/urodynamic-equipment-market-1777

Market players are actively engaged growth strategies such as mergers and acquisitions to maintain leading position in the urodynamic equipment market. For instance, in April 2018, LABORIE Medical Technologies acquired COGENTIX Medical Inc. This acquisition will help in strengthening product portfolio of LABORIE Medical Technologies. However, high cost of equipment leading to expensive treatment procedures is restraining growth of the urodynamic equipment market size.

Europe urodynamic equipment market is projected to witness significant growth over the forecast period due to increasing prevalence of urinary disorders. According to study conducted by European Association of Urology, in 2016, out of 5.3 million women in Europe 1.5 million women have urinary incontinence. According to a survey conducted by European Commission in 2017, Europe witnessed 124,000 new bladder cancer cases in 2017. Rise in the prevalence of bladder cancer and urinary incontinence is expected to fuel growth of the urodynamic equipment market. 

Urodynamic Equipment Market Key Players:-

Key players operating in global urodynamic equipment market include LABORIE Medical Technologies, Verathon, Albyn Medical, Cooper Surgical, Ameco Medical Laboratories, Aymed Medical Technology, Boston Scientific Corporation, C.R.Bard, UROTECH, NOV Amedtek, Neomedix Systems, MKS Medic, and Dantec Medical Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1777

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Digital Fluoroscopy System Market Trends Forecast Opportunity Analysis-2027

 

Digital Fluoroscopy System Market Regional Analysis:-

North America is expected to lead Digital Fluoroscopy System Market due to high prevalence of medical conditions such as varicose veins, pulmonary embolism, peripheral artery disease, and pulmonary embolism. According to a study conducted by Center for Disease Control and Prevention (CDC), in 2016, more than 8.5 million people in U.S. are suffering from peripheral artery disease, out of which more than 12% are geriatric population. According to a survey conducted by National Institute of Health (NIH), in 2016, more than 40 million people in the U.S. are diagnosed with varicose veins. Such high prevalence of diseases can drive growth of the North America digital fluoroscopy system market as digital fluoroscopy system is used for diagnosis of these diseases.

Europe digital fluoroscopy system market is expected to witness significant growth due to launch of innovative digital fluoroscopy systems. For instance, in 2015, Koninklijke Philips N.V. launched ProxiDiagnost N90 DRF system. This device is a two in one digital radiography and fluoroscopy system, which provides high quality images with fast supporting workflow and increases room utilization. This system also gives high patient accessibility i.e. the system has small footprint area, open overhead table and area this enables technicians and caregivers to be close to the patient during the procedures causing no hindrance. Moreover, in February, 2019, Siemens Healthineers (Germany) launched the Artis icono biplane, a new interventional angiography systems. This new product line is intended to support both radiology and cardiology interventional procedures using a novel detector positioning design.

Digital fluoroscopy is form of X-ray that enables technician to visualize deep structures of the body. Digital fluoroscopy provides detailed images of different organs such as intestine, cardiac muscle, bladder, and stomach. Conventional X-ray records images to a film, while digital fluoroscopy helps in recording a series of images to the computer. Digital fluoroscopy is majorly used to check and evaluate the gastrointestinal tract, which includes stomach, esophagus, duodenum and the colon.

Furthermore, it is used to diagnose tumors, ulcers, hiatal hernias, scarring, reflux, inflammation, and blockages. It examines and evaluates kidney function in venography and angiography procedures (placement of tubes in veins and arteries) and pain management procedures (nerve root blocks). Procedures that use fluoroscopy are orthopedic surgery, podiatric surgery, angiography, placement of Peripherally Inserted Central Catheter (PICC), placement of weighted feeding tube in the duodenum, urological surgery, cardiology, discography, lumbar puncture, and modified barium swallow study.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1782

Digital Fluoroscopy System Market Dynamics:-

Increasing number of orthopedic surgeries and angiography are major drivers for growth of global digital fluoroscopy system market. According to a survey conducted by American Academy of orthopedic surgeons, in 2014, more than six million patients were reported for knee replacement surgeries, more than three million patients were reported for hip replacement surgeries and more than four million patients were reported for spinal fusion surgeries.

Moreover, innovation in fluoroscopy devices is expected to fuel digital fluoroscopy system market growth. For instance, in 2015, Care Stream Health Corporation launched Carestream DRX Excel and Carestream DRX Excel Plus, this devices enhance workflow using fluoroscopy. These devices records both fluoroscopy and radiography sequences. Approvals of new products by regulatory bodies are also driving growth of the digital fluoroscopy system market size. For instance, in April 2018, Afga Healthcare received Food and Drug Administration (FDA) approval for DR multipurpose imaging system. It is a solution for digital radiography, digital fluoroscopy, and advanced clinical applications such as use of image processing software ‘DYNAMIC MUSICA’ for both static and dynamic (moving) images.

Furthermore, mergers and acquisitions by key players are boosting growth of the digital fluoroscopy system market. For instance, in 2016, Canon Inc. acquired Toshiba’s Medical Equipment Unit. Canon is focused on developing new medical imaging, digital radiography, and fluoroscopy solutions along with Health IT software solutions.

Collaborative agreement by key players for service expansion is expected to drive digital fluoroscopy system market growth. For instance, in 2015, GE Healthcare entered into a 7-year collaborative agreement with Temple University Health System to expand radiology-based services. This initiative was also undertaken to address challenges pertaining to market competition, cost control and patient outcomes.

High cost of devices and novel procedures in pipeline, which may provide better result than fluoroscopy are restraining growth of the digital fluoroscopy system market. For instance, endoscopic retrograde cholangioscopy procedure using spy glass rather than digital fluoroscopy to detect bile duct stones has completed phase three clinical trials in 2017, this is sponsored by Boston Scientific Corporation, a leading medical device company.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/digital-fluoroscopy-system-market-1782

In addition, in February 2019, Royal Philips launched Philips Zenition, its new mobile C-arm imaging platform. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including orthopedic, trauma and vascular procedures

Moreover, Asia Pacific digital fluoroscopy system market is expected to grow at significant rate due to advancement in digital fluoroscopy equipment i.e. C arms and innovation in technology of digital fluoroscopy systems. For instance, in 2016, Toshiba Corporation launched Infinix-i sky and double sliding C arm. This device helps C arms to be positioned in many ways to perform all procedures with ease. It helps the clinicians increase their speed, coverage, and patient access.

Digital Fluoroscopy System Market Key Players:-

Key players operating in global digital fluoroscopy system market include Philips Healthcare, GE Healthcare, Siemens Health, Toshiba Medical Systems, Shimadzu Medical, Ziehm Imaging, Hitachi Medical Systems, Orthoscan Inc. and Hologic Corporation.

In January 2016, Shimadzu released the Xslicer SMX-6000 Microfocus X-Ray Inspection System. This was the first System from Shimadzu that Integrated Inclined Fluoroscopy and CT Imaging into a Single Package. Besids, in October 2015, Siemens Healthcare introduced first Twin Robotic X-Ray system. This Twin Robotic X-Ray system enables a wide variety of examinations in a range of clinical areas to be performed using only a single X-ray system. In addition to this, the system also makes it possible to perform fluoroscopy examinations.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1782

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Clinical Trial Supply and Logistics Market To Surpass US$ 27.59 Billion By 2026

 

The Global Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics) was valued at US$ 14.95 Bn in 2017 and is projected to exhibit a CAGR of 7.1% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.

Various clinical trial supply and logistics management companies are indulged in offering smart tools to solve problems in delivering trial-related supplies to multiple locations, identify opportunities, reduce costs, and enhance future trials. Clinical supply management provides other supplies such as disposable products, refrigerators, centrifuges, and diagnostic, testing, and imaging medical equipment apart from the investigational medicinal products. These factors are expected to create lucrative opportunities for the manufacturers to develop drugs or technologically advanced medical devices with ease.

The shift in geographical distribution of clinical trials by various biopharmaceutical companies from regions such as Central and Eastern Europe, Asia Pacific, Latin America, and Middle East for cost-effective and quick patient recruitment is expected drive growth of the clinical trial supply and logistics market. Furthermore, Asia Pacific region provides greater economic benefits to biopharmaceutical companies, as government in China and Singapore allocate funds to promote biomedical research in the region.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1798

Also, Asia Pacific possess various kind of different diseases, which helps in conducting clinical trials with more significant results and outcome. In April 2018, Zuellig Pharma Holdings Pte. Ltd. entered into a distribution agreement with Taiho Pharma, Singapore for their product, TS-ONE OD Tablet, which is the first anticancer agent in the form of disintegrating tablet for the patients who are facing difficulty in swallowing capsules or whose water intake is restricted.

Browse 25 Market Data Tables and 44 Figures spread through 173 Pages and in-depth TOC on "Clinical Trial Supply and Logistics Market, By Service (Manufacturing, Packaging and Labeling, and Distribution), By End User (Pharmaceutical, Medical Devices, and Biologics) - Global Forecast to 2026"

Clinical trial suppliers and logistics focuses on organic and inorganic growth strategies such as mergers and acquisitions, and launch of various clinical programs, which in turn is expected to augment growth of the market during the forecast period. For instance, in November, 2016, Bionical, global supplier of commercial pharmaceutical products, acquired a global Clinical Research Organisation named EMAS Pharma to expand its clinical service business footprint globally and to unify and complete Bionical’s patient-centric service portfolio.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/clinical-trial-supply-and-logistics-market-1798

Key takeaways of the clinical trial supply and logistics market:

The global clinical trial supply and logistics market is expected to expand at a CAGR of 7.1% during the forecast period (2018 – 2026), owing to increasing number of clinical trials, increasing complexities, and rising number of biologics and biosimilar drugs in trials

On the basis of service, distribution segment is expected to show maximum traction during the forecast period, owing to the rising outsourcing storage and distribution facility

On the basis of end user, pharmaceutical segment holds largest market share, owing to increasing research activities for oncology therapeutic application. However, steady decrease in R&D pipeline for pharmaceutical drugs has been observed and it is being substituted by biological drugs, which is expected to impact the segment over the next eight years.

Some of the major players operating in the global clinical trial supply and logistics market include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1798

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Lidocaine Patches Market Size Share Trends Forecast Opportunity Analysis 2026

 

Lidocaine Patches Market Dynamics

Increasing number generic approved product in the market are expected to augment the Lidocaine Patches Market growth. Patent expiry of Endo Pharmaceuticals for Lidoderm offers growth opportunity for market players to develop generic version of the lidocaine patch. For instance, in 2015, Mylan Pharmaceuticals, Inc., launched the generic version of Endo Pharmaceutical's Lidoderm in the U.S. market. In 2014, Galen US Incorporated receive FDA approval for Synera, lidocaine and tetracaine topical patch for domestic use. Moreover, companies are introducing advanced technologies in lidocaine patches in order to maintain leading position in market, For instance, in 2016, Gregory Pharmaceutical Holdings, Inc. launched Lidocare, which is first and only patch that is water-free. Lidocare is the new over-the-counter/non-prescription lidocaine pain patch and the technology is under the patenting process. In February 2018, Sorrento Therapeutics, Inc., a subsidiary of Scilex Pharmaceuticals Inc., received U.S. FDA approval for ZTlido 1.8%, with the company’s proprietary adhesion technology. Furthermore, companies are also conducting clinical trials for expanding the application of lidocaine patch for disease and conditions such as Endo Pharmaceuticals, Inc., is conducting clinical trial for the use of lidocaine patch in osteoarthritis, chronic lower back pains, Carpal Tunnel Syndrome etc.

Lidocaine is an aminoethylamide local and topical anesthetic medication, causing temporary numbness or loss of sensation in the area of application. Lidocaine blocks the voltage-gated sodium channels of nerve membranes, thereby preventing the generation and conduction of nerve impulses and providing analgesic relief.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1805

Lidocaine patch 5% comprises a soft, stretchy adhesive patch containing 5% lidocaine for the topical treatment of pain associated with Post Herpetic Neuralgia (PHN). The first FDA approved transdermal lidocaine patch was Lidoderm, in 1999, by Endo Pharmaceuticals Inc. Increasing incidence of back and neck pain is the key factors driving growth of the market. However, availability of alternatives for the pain management such as other pain killer drugs are expected to restrain growth of the lidocaine patches market growth.

Increasing incidence of the shingles is expected to fuel growth of the lidocaine patches market during the forecast period. Shingles, also known as herpes zoster, leads to the chronic pain known as Post Herpetic Neuralgia (PHN) in which lidocaine patches are used. According to Centers for Disease Control and Prevention (CDC), January 2018, an estimated one third of the total U.S. population develops shingles during their lifetime, which suggests nearly 1 million Americans experiences shingles infection annually. Furthermore, CDC estimated that around 10 to 15% people with shingles infection experience PHN.

Lidocaine Patches Market - Regional Analysis

Regional segmentation of lidocaine patches market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America lidocaine patches market holds dominant position, owing to large number of product launches by the regional players and strategic collaborations among market players to introduce their product in regional market. For instance, Galen’s acquisition of Synera patch, a product of Nuvo Research, to commercialize the product in U.S. lidocaine patches market. Furthermore, reimbursement policies in North America related to lidocaine patch are supporting the market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/lidocaine-patches-market-1805

Moreover, Asia Pacific Lidocaine Patches Market is expected to witness fast growth attributed to increasing incidence of herpes zoster in these region and lack of preventive vaccination against shingles, which is expected to boost the lidocaine patches market growth.

Lidocaine Patches Market - Competitive Analysis

This market is highly fragmented, with the presence of Mylan Pharmaceuticals Inc., Endo Pharmaceutical Inc., Teva Pharmaceutical, Inc., Teikoku Pharma USA, Hisamitsu Pharmaceuticals Co. Inc., Galen US Inc., Sorrento Therapeutics, Inc. and Actavis Labs UT Inc. market players.

Manufacturers are focused on acquisition of complementary companies to enter the market with advanced products in lidocaine patches. For instance, in 2013, Galen entered into a product acquisition and license agreement with Nuvo Research Inc. pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain. Acquisition offers exclusive rights to market and sell Nuvo's Synera patch throughout the U.S. for its current indication. Under these agreement Nuvo Research Inc. will receive royalties of 10% of net sales.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1805

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737